Scrip Podcast-Ep4 March 2020:Coronavirus:Remdesivir and Pipeline Hopes–Long-Term Impact On Biopharma

Citeline Podcasts

English - March 30, 2020 07:31 - 53 minutes - 26.7 MB - ★★★★★ - 24 ratings
Business News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Coronavirus Stimulus Bill, Remdesivir’s Orphan Status, Teva’s Copaxone Suit

Next Episode: CDER’s Woodcock Talks About The Impact Of COVID-19

A special edition focused on biopharma and the coronavirus pandemic. Taking a look at the coronavirus pipeline, including Gilead’s remdesivir ‘The People’s Hope’; has China beaten COVID-19? Plus the long-term impact on pharma R&D and commercial operations.
Hosted by Andrew McConaghie, Brian Yang and Kevin Grogan from the Scrip Pharma Intelligence team in the UK and Beijing.